共 50 条
- [1] Comparison of the pharmacokinetics between a COMT-inhibitor and levodopa[J]. MOVEMENT DISORDERS, 2011, 26 : S283 - S283Nagai, M.Kubo, M.Kyaw, W. T.Nishikawa, N.Nomoto, M.
- [2] Effect of COMT-inhibitor on Parkinson's disease associated with dementia[J]. MOVEMENT DISORDERS, 2013, 28 : S181 - S181Park, J. W.Lee, K. S.Song, I. U.Kim, J. S.Kim, Y. D.
- [3] Effect of COMT-inhibitor in the clinical progression of Parkinson's disease[J]. MOVEMENT DISORDERS, 2018, 33 : S120 - S120Song, I. U.Lee, K. S.Chung, Y. A.
- [4] NEW POSSIBILITY FOR AFFECTING ADRENERGIC NEUROTRANSMISSION WITH SELECTIVE COMT-INHIBITOR AMINOPHTHALIDES[J]. ACTA PHYSIOLOGICA ACADEMIAE SCIENTIARUM HUNGARICAE, 1979, 53 (02): : 222 - 223THURANSZKY, KSZEBENI, A
- [5] Sleep attacks in Parkinson's disease induced by entacapone, a COMT-inhibitor[J]. FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2003, 17 (01) : 121 - 123Santens, P
- [6] GASTRIC-MUCOSAL PROTECTION IN THE RAT BY OR-462, A NOVEL COMT-INHIBITOR[J]. DIGESTIVE DISEASES AND SCIENCES, 1988, 33 (07) : 897 - 897AHO, PLINDEN, IBNISSINEN, EPOHTO, P
- [7] PREVENTION OF CYSTEAMINE-INDUCED DUODENAL-ULCERS IN RATS BY A COMT-INHIBITOR[J]. DIGESTIVE DISEASES AND SCIENCES, 1988, 33 (07) : 905 - 905AHO, PLINDEN, IBNISSINEN, EPOHTO, P
- [8] Premature wearing-off of levodopa: (fixed) combination with COMT-inhibitor is meaningful[J]. PSYCHOPHARMAKOTHERAPIE, 2009, 16 (01): : 40 - 41Blaeser-Kiel, Gabriele
- [9] Does previous COMT-inhibitor affect outcomes of Opicapone Therapy: retrospective subgroup analysis?[J]. JOURNAL OF NEURAL TRANSMISSION, 2019, 126 (05) : 659 - 660Oehlwein, ChristianMittmann, KatrinOehlwein, MaritaBaron, JohannesSarkisjan, Diana
- [10] EFFECT OF THE NOVEL COMT-INHIBITOR TOLCAPONE ON L-DOPA PHARMACOKINETICS WHEN COMBINED WITH DIFFERENT SINEMET FORMULATIONS[J]. NEUROLOGY, 1995, 45 (04) : A291 - A291JORGA, KMSEDEK, G